Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease-Reference-Cited by-同舟云学术

Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease

Published:2018-05-14 Issue:12 Volume:38 Page:2137-2148
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Manoj Kumar ¹^ORCID,Nayak Suman L.²,Gupta Ekta³,Kataria Ashish²,Sarin Shiv K.¹^ORCID

Affiliation:

1. Department of Hepatology and Liver Transplatation; Institute of Liver and Biliary Sciences; New Delhi India

2. Department of Nephrology; Institute of Liver and Biliary Sciences; New Delhi India

3. Department of Virology; Institute of Liver and Biliary Sciences; New Delhi India

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13863/fullpdf

Reference32 articles.

1. Hepatitis C virus and kidney disease;Martin;J Hepatol,2008

2. The impact of hepatitis C virus infection on survival in dialysis patients:meta-analysis of observational studies;Fabrizi;J Viral Hepat,2007

3. Gilead Sciences, Inc Sovaldi 400 mg tablets (sofosbuvir) product monograph 2014 http://www.gilead.ca/pdf/ca/sovaldi_pm_english.pdf

4. Gilead Sciences, Inc Sofosbuvir for treatment of chronic hepatitis C infection. Antiviral drugs advisory committee meeting briefing document 2013 http://www.fda.gov/downloads/advisorycommittees/committees meeting materials/drugs/antiviral drugs advisorycommittee/ucm371877.pdf

5. Antiviral efficacy and pharmacokinetics (PK) of Sofosbuvir (SOF) in patients with severe renal impairment;Gane;Hepatology,2014

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of direct-acting antiviral regimens for end-stage renal disease patients with HCV infection: a systematic review and network meta-analysis;Frontiers in Public Health;2023-09-29

2. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

3. Real-World Therapeutic Outcomes of Direct-Acting Antiviral Regimens and Formidable Challenges;Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives;2023-01

4. Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study;Archives of Medical Research;2022-11

5. Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta‐analysis;Nephrology;2021-09-14